Lbel Effet Parfait Signs Of Age Appearance Minimizer Foundation Spf 20 Fm Medium 6
Octinoxate, Titanium Dioxide
Bel Star S.a. (colombia)
Human Otc Drug
NDC 14141-888Lbel Effet Parfait Signs Of Age Appearance Minimizer Foundation Spf 20 Fm Medium 6 also known as Octinoxate, Titanium Dioxide is a human otc drug labeled by 'Bel Star S.a. (colombia)'. National Drug Code (NDC) number for Lbel Effet Parfait Signs Of Age Appearance Minimizer Foundation Spf 20 Fm Medium 6 is 14141-888. This drug is available in dosage form of Emulsion. The names of the active, medicinal ingredients in Lbel Effet Parfait Signs Of Age Appearance Minimizer Foundation Spf 20 Fm Medium 6 drug includes Octinoxate - 7 g/100mL Titanium Dioxide - 2.44 g/100mL . The currest status of Lbel Effet Parfait Signs Of Age Appearance Minimizer Foundation Spf 20 Fm Medium 6 drug is Active.
Drug Information:
| Drug NDC: | 14141-888 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Lbel Effet Parfait Signs Of Age Appearance Minimizer Foundation Spf 20 Fm Medium 6 |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Octinoxate, Titanium Dioxide |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Bel Star S.a. (colombia) |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Emulsion |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | OCTINOXATE - 7 g/100mL
TITANIUM DIOXIDE - 2.44 g/100mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 30 Jul, 2021 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 22 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part352 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Bel Star S.A. (Colombia)
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | 4Y5P7MUD51
15FIX9V2JP
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 14141-888-01 | 30 mL in 1 BOX (14141-888-01) | 30 Jul, 2021 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Uses helps prevent sunburn
Product Elements:
Lbel effet parfait signs of age appearance minimizer foundation spf 20 fm claire 2 octinoxate, titanium dioxide butylene glycol caprylyl glycol .alpha.-tocopherol acetate hydrogen dimethicone (13 cst) titanium dioxide titanium dioxide water cyclomethicone 6 peg/ppg-18/18 dimethicone cetyl peg/ppg-10/1 dimethicone (hlb 2) polyglyceryl-4 isostearate aluminum oxide cyclomethicone 5 trimethylsiloxysilicate (m/q 0.6-0.8) peg-10 dimethicone (600 cst) glycerin sodium chloride phenoxyethanol triethoxycaprylylsilane carbomer homopolymer, unspecified type silica dimethyl silylate octinoxate octinoxate poly(methyl methacrylate; 450000 mw) butylated hydroxytoluene chlorphenesin polysorbate 20 palmitoyl tripeptide-1 palmitoyl tetrapeptide-7 hydroxyacetophenone hexyl laurate ferric oxide red lbel effet parfait signs of age appearance minimizer foundation spf 20 fm medium 5 octinoxate, titanium dioxide butylene glycol caprylyl glycol .alpha.-tocopherol acetate hydrogen dimethicone (13 cst) titanium dioxide titanium dioxide water cyclomethicone 6 peg/ppg-18/18 dimethicone cetyl peg/ppg-10/1 dimethicone (hlb 2) polyglyceryl-4 isostearate aluminum oxide cyclomethicone 5 trimethylsiloxysilicate (m/q 0.6-0.8) peg-10 dimethicone (600 cst) glycerin sodium chloride phenoxyethanol triethoxycaprylylsilane carbomer homopolymer, unspecified type silica dimethyl silylate octinoxate octinoxate poly(methyl methacrylate; 450000 mw) butylated hydroxytoluene chlorphenesin polysorbate 20 palmitoyl tripeptide-1 palmitoyl tetrapeptide-7 hydroxyacetophenone hexyl laurate ferric oxide red lbel effet parfait signs of age appearance minimizer foundation spf 20 fm medium 6 octinoxate, titanium dioxide butylene glycol caprylyl glycol .alpha.-tocopherol acetate hydrogen dimethicone (13 cst) titanium dioxide titanium dioxide water cyclomethicone 6 peg/ppg-18/18 dimethicone cetyl peg/ppg-10/1 dimethicone (hlb 2) polyglyceryl-4 isostearate aluminum oxide cyclomethicone 5 trimethylsiloxysilicate (m/q 0.6-0.8) peg-10 dimethicone (600 cst) glycerin sodium chloride phenoxyethanol triethoxycaprylylsilane carbomer homopolymer, unspecified type silica dimethyl silylate octinoxate octinoxate poly(methyl methacrylate; 450000 mw) butylated hydroxytoluene chlorphenesin polysorbate 20 palmitoyl tripeptide-1 palmitoyl tetrapeptide-7 hydroxyacetophenone hexyl laurate ferric oxide red lbel effet parfait signs of age appearance minimizer foundation spf 20 fm claire 4 octinoxate, titanium dioxide butylene glycol caprylyl glycol .alpha.-tocopherol acetate hydrogen dimethicone (13 cst) titanium dioxide titanium dioxide water cyclomethicone 6 peg/ppg-18/18 dimethicone cetyl peg/ppg-10/1 dimethicone (hlb 2) polyglyceryl-4 isostearate aluminum oxide cyclomethicone 5 trimethylsiloxysilicate (m/q 0.6-0.8) peg-10 dimethicone (600 cst) glycerin sodium chloride phenoxyethanol triethoxycaprylylsilane carbomer homopolymer, unspecified type silica dimethyl silylate octinoxate octinoxate poly(methyl methacrylate; 450000 mw) butylated hydroxytoluene chlorphenesin polysorbate 20 palmitoyl tripeptide-1 palmitoyl tetrapeptide-7 hydroxyacetophenone hexyl laurate ferric oxide red lbel effet parfait signs of age appearance minimizer foundation spf 20 fm claire 3 octinoxate, titanium dioxide butylene glycol caprylyl glycol .alpha.-tocopherol acetate hydrogen dimethicone (13 cst) titanium dioxide titanium dioxide water cyclomethicone 6 peg/ppg-18/18 dimethicone cetyl peg/ppg-10/1 dimethicone (hlb 2) polyglyceryl-4 isostearate aluminum oxide cyclomethicone 5 trimethylsiloxysilicate (m/q 0.6-0.8) peg-10 dimethicone (600 cst) glycerin sodium chloride phenoxyethanol triethoxycaprylylsilane carbomer homopolymer, unspecified type silica dimethyl silylate octinoxate octinoxate poly(methyl methacrylate; 450000 mw) butylated hydroxytoluene chlorphenesin polysorbate 20 palmitoyl tripeptide-1 palmitoyl tetrapeptide-7 hydroxyacetophenone hexyl laurate ferric oxide red
Indications and Usage:
Stop use and ask a doctor if rash occurs.
Warnings:
Warnings skin cancer / skin aging alert: spending time in the sun increases your risk of skin cancer and early skin aging. this product has shown only to help prevent sunburn, not skin cancer or early skin aging. for external use only. do not use on damaged or broken skin. when using this product keep out of eyes. rinse with water to remove.
Dosage and Administration:
Directions apply liberally and evenly 15 minutes before sun exposure. children under 6 months of age: ask a doctor reapply at least every 2 hours use a water resistant sunscreen if swimming or sweating
Package Label Principal Display Panel:
Effet parfait foundation claire 2 l'bel effet parfait signs of age appearance minimizer foundation spf 20 fm 1.01 fl. oz. (30 ml) tone claire 2 claire 2 foundation
Effet parfait foundation claire 3 l'bel effet parfait signs of age appearance minimizer foundation spf 20 fm 1.01 fl. oz. (30 ml) claire 3 effet parfait foundation claire 3
Effet parfait foundation claire 4 l'bel effet parfait signs of age appearance minimizer foundation spf 20 fm 1.01 fl. oz. (30 ml) claire 4 effet parfait foundation claire 3
Effet parfait foundation medium 5 l'bel effet parfait signs of age appearance minimizer foundation spf 20 fm 1.01 fl. oz. (30 ml) effet parfait foundation medium 5
Effet parfait foundation medium 6 l'bel effet parfait signs of age appearance minimizer foundation spf 20 fm 1.01 fl. oz. (30 ml) medium 6 effet parfait foundation medium 6